ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,541,745 | -10.4% | 1,681,199 | 0.0% | 1.37% | +42.1% |
Q2 2023 | $14,004,388 | -37.4% | 1,681,199 | 0.0% | 0.97% | -37.7% |
Q1 2023 | $22,359,947 | +89221.9% | 1,681,199 | 0.0% | 1.55% | -46.1% |
Q4 2022 | $25,033 | -99.7% | 1,681,199 | +68.1% | 2.88% | +188.8% |
Q3 2022 | $9,040,000 | – | 1,000,000 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 1,347,088 | $17,916,270 | 9.94% |
Fairmount Funds Management LLC | 1,901,397 | $25,288,580 | 4.35% |
Ikarian Capital, LLC | 869,390 | $11,562,887 | 2.62% |
Affinity Asset Advisors, LLC | 529,369 | $7,040,608 | 2.32% |
Logos Global Management LP | 1,044,960 | $13,897,968 | 1.99% |
Ghost Tree Capital, LLC | 450,000 | $5,985,000 | 1.77% |
Vivo Capital, LLC | 1,681,199 | $22,359,947 | 1.55% |
Opaleye Management Inc. | 302,000 | $4,096,400 | 1.23% |
Tri Locum Partners LP | 275,011 | $3,657,646 | 1.11% |
Saturn V Capital Management LP | 101,339 | $1,347,809 | 1.01% |